[Clinical observation on specific immunotherapy of allergic rhinitis with artemisia pollen].
LIN CHUANG ER BI YAN HOU TOU JING WAI KE ZA ZHI = JOURNAL OF CLINICAL OTORHINOLARYNGOLOGY, HEAD, AND NECK SURGERY 2018;
32:1580-1583. [PMID:
30400711 DOI:
10.13201/j.issn.1001-1781.2018.20.011]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 06/07/2018] [Indexed: 11/12/2022]
Abstract
Objective:The aim of this study is to observe the clinical efficacy of pollen specific immunotherapy with Artemisia in allergic rhinitis. Method:A total of 139 patients with allergic rhinitis who were positive for Artemisia pollen were selected for allergen skin pricking. All of them were treated with Artemisia pollen-specific immunotherapy. The patients were followed-up for 3 months, respectively before treatment (N), after treatment start interval. 3 months (D1, D2, D3) followup fill in the total score of nasal symptoms (TNSS), visual analogue scale (VAS) score, olfactory function grading, ocular symptom score (TOSS) and rhinoconjunctivitis quality of life questionnaire (RQLQ) )score. Result:TNSS:N>D1,N>D2,N>D3,D1,D2,D3 two of the three compared to no difference.VAS:N>D1,N>D2,N>D3,among D1,D2,D3, two of the three compared to no difference. Olfactory function classification:N>D1,N>D2,N>D3,among D1,D2,D3, two of the three compared to no difference.TOSS:N>D1,N>D2,N>D3,among D1,D2,D3,D1>D2,the rest had no difference. RQLQ: N>D1, N>D2, N>D3, D1>D2, D3>D1, D3>D2. Conclusion:The specific pollen immunotherapy of artemisia is effective in the treatment of allergic rhinitis, and the symptoms are obviously improved.
Collapse